Substaging of intermediate hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|30|2|358-363

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.30, Iss.2, 2015-02, pp. : 358-363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma

By  

Oncology, Vol. 89, Iss. 2, 2015-0 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

Percutaneous Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma

By  

Oncology, Vol. 89, Iss. 2, 2015-0 ,pp. : 19-26

Karger

Access to resources Recommend Favorite

Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 330-341

Karger

Access to resources Recommend Favorite

Treatment Algorithm for Intermediate and Advanced Stage Hepatocellular Carcinoma: Korea

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 141-147

Karger

Access to resources Recommend Favorite

When to perform hepatic resection for intermediate‐stage hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 905-914

John Wiley & Sons Inc

Access to resources Recommend Favorite